Bank of New York Mellon Corp Has $73.34 Million Stock Holdings in Cognex Corporation $CGNX

Bank of New York Mellon Corp cut its position in Cognex Corporation (NASDAQ:CGNX) by 32.6% during the 4th quarter, HoldingsChannel reports. The firm owned 2,038,434 shares of the scientific and technical instruments company’s stock after selling 985,921 shares during the quarter. Bank of New York Mellon Corp’s holdings in Cognex were worth $73,343,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. REAP Financial Group LLC acquired a new stake in Cognex in the third quarter worth $27,000. Geneos Wealth Management Inc. raised its holdings in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the period. CIBC Private Wealth Group LLC raised its holdings in shares of Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the period. Miller Global Investments LLC acquired a new stake in shares of Cognex during the fourth quarter worth $39,000. Finally, Larson Financial Group LLC raised its holdings in shares of Cognex by 202.7% during the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after acquiring an additional 740 shares during the period. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CGNX has been the topic of a number of research analyst reports. Robert W. Baird set a $72.00 price objective on shares of Cognex in a report on Friday, May 8th. Weiss Ratings restated a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. Truist Financial set a $61.00 price objective on shares of Cognex and gave the stock a “hold” rating in a report on Friday, May 8th. TD Cowen restated a “buy” rating on shares of Cognex in a report on Tuesday, February 17th. Finally, DA Davidson set a $62.00 price objective on shares of Cognex and gave the stock a “neutral” rating in a report on Thursday, May 14th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.43.

Cognex Price Performance

Shares of CGNX opened at $61.32 on Wednesday. The firm has a 50-day moving average of $58.89 and a 200-day moving average of $48.91. Cognex Corporation has a one year low of $29.22 and a one year high of $71.90. The company has a market cap of $10.20 billion, a PE ratio of 73.00 and a beta of 1.52.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. The company had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company’s quarterly revenue was up 24.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Analysts expect that Cognex Corporation will post 1.41 earnings per share for the current year.

Cognex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Investors of record on Thursday, May 21st were issued a dividend of $0.085 per share. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.6%. Cognex’s payout ratio is presently 40.48%.

Insiders Place Their Bets

In other Cognex news, VP Darren Marc Long sold 20,252 shares of Cognex stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the sale, the vice president owned 3,990 shares in the company, valued at $264,696.60. The trade was a 83.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Laura Ann Macdonald sold 41,600 shares of Cognex stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the completion of the sale, the vice president owned 5,258 shares of the company’s stock, valued at $344,714.48. This trade represents a 88.78% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 224,847 shares of company stock worth $14,975,098 in the last quarter. 1.70% of the stock is currently owned by corporate insiders.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.